Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
At PEAK, every patient receives a full clinical program not just a prescription
Combination focus: Much of its regulatory development is tied to dual-therapy use with GLP-1 drugs, positioning it as a combination obesity therapy rather than a standalone peptide
Scientific Background and Research Importance Synthetic peptides play a foundational role in modern biochemical and biomedical research due to their precision and reproducibility
Before procedures/anesthesia: Current multi-society guidance says most patients can continue GLP-1s, but plans should be individualized with your surgeon/anesthesiologistespecially if you have significant GI symptoms
If a prescriber determines that BPC-157 therapy is warranted, starting at 150-200 mcg once daily with twice-weekly lab monitoring represents the most cautious approach
